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Abstract
The IGF-1 mediated AKT/mTOR pathway has been recently proposed
as mediator of skeletal muscle growth and a positive feedback between Akt
and mTOR was suggested to induce homogenous growth signals along the
whole spatial extension of such long cells. Here we develop two biologically
justified approximations which we study under the presence of four different
initial conditions that describe different paradigms of IGF-1 receptor–induced
Akt/mTOR activation. In first scenario the activation of the feedback cas-
cade was assumed to be mild or protein turnover considered to be high. In
turn, in the second scenario the transcriptional regulation was assumed to
maintain defined levels of inactive pro–enzymes. For both scenarios, we were
able to obtain closed–form formulas for growth signal progression in time and
space and found that a localised initial signal maintains its Gaussian shape,
but gets delocalised and exponentially degraded. Importantly, mathemati-
cal treatment of the reaction diffusion system revealed that diffusion filtered
out high frequencies of spatially periodic initiator signals suggesting that the
muscle cell is robust against fluctuations in spatial receptor expression or ac-
tivation. However, neither scenario was consistent with the presence of stably
travelling signal waves. Our study highlights the role of feedback loops in
spatiotemporal signal progression and results can be applied to studies in cell
∗Corresponding author. Tel.: + 353 1 402 8538; Fax: + 353 1 402 2447.
Email address: Heinhuber@rcsi.ie (Heinrich J. Huber)
Preprint submitted to Journal of Theoretical Biology November 24, 2011
proliferation, cell differentiation and cell death in other spatially extended
cells.
Keywords: AKT/mTOR, Skeletal muscle, Positive feedback, Protein
activation, PDE, Analytical solutions
1. Introduction
The Insulin-like growth factor (IGF-1) receptor pathway is a canonical
pathway that mediates cell growth and survival. Upon growth factor binding
to the receptor, the lipid kinase phosphoinositide-3-OH kinase (PI3K) gets
phosphorylated and activated. This activation leads to phosphorylation and
activation of the pro–survival kinase Akt. Through a double inhibitory step,
active Akt leads to the activation of the mammalian target of rapamycin
(mTOR) which switches on anabolic processes such as protein or nucleotide
production. In turn, evidence has been provided that mTOR can phosphory-
late and activate Akt [15, 31], thereby establishing a positive feedback loop.
Recent reports suggested the IGF-1 mediated PI3K-/Akt-/mTOR path-
way to be a regulator of muscle cell growth. Indeed, studies that over-
expressed active AKT by genetic mutations or pharmacological activation
reported an increase in muscle fibre diameter (muscular hypertrophy) while
muscle fibre diameter decreased upon inhibition of Akt or mTOR (muscular
atrophy) [26, 3, 29]. Trophic factor receptors such as IGF-1 can be ran-
domly and anisotropically distributed along the cell surface [14, 17, 35] and
activation of Akt by PI3K has been determined to be localised at the recep-
tors. Therefore it remains to be understood how a signal that is associated
with certain locations on the surface of a muscle cell can proceed through
the entire spatial extension of this cell in a homogenous fashion. Diffusion
alone cannot be responsible for eliminating spatial gradients in larger cells
as protein motility is limited by ubiquitenation and degradation of activated
proteins [16]. It is therefore assumed that the Akt/mTOR positive feedback
loop acts as a signal regenerator [9, 21, 33] in larger cells.
In this study, we will investigate a mathematical model that studies
Akt/mTOR signal progression in skeletal muscle cells with an anisotropic
distribution of IGF-1 receptors on the muscle cell surface. We will focus on
an analytical treatment to study whether general principes of the resulting
reaction diffusion equation can be derived. We will first discuss the time
dependent, spatially invariant reaction system of a simple auto-activation
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network of Akt/mTOR and obtain criteria for stable enzyme activation.
Subsequently, we will include one spatial dimension, so as to idealize the
muscle cell as a linearly extended compartment and focus on two biologically
reasonable scenarios that we solve in the presence of four different initiator
signals. While no travelling waves are present under these assumptions, we
will observe that the feedback loop together with diffusion can filter out spa-
tial anisotropies. This filtering allows the translation of anisotropies arising
from an inhomogenous distribution of IGF-receptor or from fluctuations in
the initiator signals into a homogenous Akt/mTOR activation along the cell.
We will further discuss the implications of our findings on receptor mediated
activation in other large cells such as nerve cells.
2. Temporal dynamics of the Akt/mTOR autoactivation network
As we strive to obtain analytical solutions, we keep our system simple
and represent it as a motif that is ubiquitously present in signalling path-
ways (see for example [16]). We concentrate on a time dependent analysis of
the positive feedback loop to better characterise the basic feature of our reac-
tion cascade. Instead of investigating a mutual activation between Akt and
mTOR, we abstract the entire Akt/mTOR cassette into single node which
activates itself. This assumption is justified when mTOR levels vary more
slowly than Akt, or the pool of mTOR is abundant in comparison to that of
Akt, as shown in Appendix 7.1. We further include a potential inhibitor of
this Akt/mTOR node, which could be an Akt pharmacological antagonist,
the Akt inhibitor Phospholipid Phosphatase SHIP-2 [34], or the tumour sur-
pressor kinase Protease and tensin homolog (PTEN) [22, 23]. Moreover, we
assume that the Akt/mTOR form gets produced as inactive pro–form (P )
and gets degraded when it is active (A). Only the active form is assumed to
effect downstream signalling [23]. The resulting network is defined by
P + A
k1−→ 2A (1a)
A
k2−→ 0 (1b)
P
k3f−−⇀↽−
k3b
0 (1c)
A+ I
k4−→ 0 (1d)
I
k5f−−⇀↽−
k5b
0. (1e)
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Upon the presence of an active form A, the inactive pro–form P gets
activated (auto–activation, (1a)). In the kinetics of the auto–activation (1b),
k1 is set proportional to the product of the amount of the active and of
the inactive form (consistent with the assumption of mass-action kinetics).
The active form is assumed to get degraded (1b) and this degradation rate is
assumed to be proportional to its concentration (factor k2). Protein turnover
was modelled to establish the pro–form P and the inhibitor I at constant
expression levels (1c) and (1e), respectively. This was achieved by balancing
protein production (linear factors k3b and k5b for inactive form and inhibitor)
with protein degradation (first order proportionality constants k3f and k5f ).
Inhibition of the active form is assumed according mass action kinetics (1d).
Defining the vector c = (c1 c2 c3)
T := ([P ] [A] [I])T ∈ R3+, we obtain the
following set of coupled ordinary differential equations (ODE) (see [18], for
details)
c˙1 = −k3fc1 − k1c1c2 + k3b (2a)
c˙2 = −k2c2 + k1c1c2 − k4c2c3 (2b)
c˙3 = −k5fc3 − k4c2c3 + k5b. (2c)
Without the inhibitor, we obtain
c˙1 = −k3fc1 − k1c1c2 + k3b (3a)
c˙2 = −k2c2 + k1c1c2. (3b)
Due to the nonlinearity of this equation, a straightforward mathematical
solution of the temporal dynamics is not possible. However, we can calculate
the steady state protein levels for the inactive form (c¯1) and the active form
(c¯2) in the auto–activation cascade,
off state: = {c¯1,off , c¯2,off} =
{
k3b
k3f
, 0
}
(4a)
on state: = {c¯1,on, c¯2,on} =
{
k2
k1
,
k3b
k2
− k3f
k1
}
. (4b)
Here, we have denoted the state where no active form is present as the ‘off
state’ while the other state was denoted as ‘on state’. We next investigated
under what conditions these steady states are stable against small pertur-
bation. Such a local stability analysis has been extensively described by [7].
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In brief, local stability requires that the eigenvalues of the Jabocian matrix
that were derived from the system (2a)–(2c) have negative real parts. The
eigenvalues are roots of the characteristic polynomial
P (s) = s2 + (k1 [c¯2 − c¯1] + k2 + k3f ) s+ k1 (k2c¯2 − k3f c¯1) + k2k3f .
The Routh–Hurwitz criterion applied to a second order polynomial, states
that the roots of such a polynomial will be negative, when all the coefficients
have the same sign. From this criterion, we conclude that the ‘off steady
state’ will be locally stable if and only if k1 < k2 k3f/k3b; in turn, for the ‘on
steady state’ to be stable, we require k1 > k2 k3f/k3b.
Figure 2(a) depicts the location and stability of the steady states for c2
as a function of the feedback strength (k1). While a value less than 0.04
[(µM min)−1] renders the ‘off state’ stable (solid line), this state becomes
unstable (dashed line) for k1 > 0.04[(µM min)
−1]. For values above this
threshold, the ‘on state’ becomes positive and stable, therefore biologically
meaningful. Similar results can be obtained for analysing the stability of both
states in dependence of other kinetic parameters. We conclude that a stable
activation is not always present, but requires the condition k2/k1 < k3b/k3f
to be fulfilled. If the conditions of a stable state are not met, any initial
activation will go back to zero over time. Whenever conditions for a stable
‘on state’ are met, both active and inactive forms will eventually converge to
this state (see trajectories, and phase portrait in Figure 2(b–d)). In Figure
2(d), the solid line represents an orbit of the system that converges to the
stable steady state. Similarly, the orbit represented by the dotted line, will
converge to the stable steady state, even if its initial condition is very close
to the unstable steady state. In contrast, the orbit whose initial condition
lies in the axis c2(t) = 0 will converge to the unstable steady state. This
shows that this unstable steady state is a saddle point.1 In turn, the stable
steady state is a focus.
3. Spatio–temporal dynamics of Akt/mTOR autoactivation
While in the last section we concentrated on the temporal regulation
of the auto–activation network and studied the systems under equilibrium
1In fact, all the orbits which start in the axis c2(t) = 0, will converge to the unstable
steady state since this is the stable manifold of the saddle point.
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conditions, we are now interested in the spatial and temporal dynamics of
the active form c2(t, x). We will model the muscle cell as a cell with large
spatial extension, therefore neglect its diameter and consider a one dimen-
sional spatiotemporal model. In addition, we assume that IGF receptors are
anisotropically distributed along the cell surface where they lead to an ini-
tial Akt/mTOR activation. We finally assume that active Akt/mTOR will
exercise its effect at each spatial location where it is present.
By including one dimensional diffusion according Fick’s laws [2], the equa-
tion system (2) transforms into the following set of Partial Differential Equa-
tions (PDEs),
∂
∂t
c1 = d1∇2xc1 − k3fc1 − k1c1c2 + k3b (5a)
∂
∂t
c2 = d2∇2xc2 − k2c2 + k1c1c2 − k4c2c3 (5b)
∂
∂t
c3 = d3∇2xc3 − k5fc3 − k4c2c3 + k5b, (5c)
with the diffusion constants d1, d2, d3 for inactive form, active form and
inhibitor.
We first note that the steady states of the space independent scenario
(4) are also steady states of the reaction diffusion equation (5). Neverthe-
less, the stability of the such fixed points become a more subtle topic in this
spatiotemporal frame. We will comment on their stability, once we derive
the analytical solutions. Again, the system (5) is nonlinear and a straight-
forward analytical solution is not possible. We therefore define and explore
two biological scenarios that allow for an analytical solution under given as-
sumptions. In Scenario 1, we will consider the inhibitor [I] and the inactive
pro–form [P ] as constant in both space and time, considering a situation
where auto–activation is mild or replenishment of the inactive form and in-
hibitor is fast. In Scenario 2, we will assume that a temporal profile for [P ]
is given for all times which assumes that protein levels of the inactive pro–
form are regulated by other processes than by auto–activation, such as by
transcription or degradation. In both scenarios, we can describe the systems
dynamics by the reduced model
∂
∂t
c2 = d2∇2xc2 + αc2. (6)
Here
α = k1c1(t, x)− k4c3(t, x)− k2. (7)
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To initiate the signalling network (5) appropriate initial conditions have
to be chosen. We assume that an initial Akt/mTOR activity is present due
to IGF-receptor activation
IC1. Point–like activation: By this initial condition, we assume a point-
like, activation of Akt/mTOR at a particular spatial location. Local
enzyme activities may be spontaneously present at a certain location
due to intrinsic noise [6].
IC2. Receptor activation: Here we assume an IGF-receptor enriched mem-
brane region which leads to activation of Akt/mTOR.
IC3. Localised depression of activation: With this initial condition, we
assume that most of the muscle cell surface is covered by activated IGF
receptors, while a particular spatial region is deprived of receptors or
these receptors are blocked. This blockage may be due to a locally
acting antagonist that prevents active receptors or due to the fact that
parts of the cell surface is not accessible for activation (due to gap or
tight juctions [12]).
IC4. Arbitrary initiator signal: This is the most general situation, where
we consider an anisotropically distributed expression of IGF receptors
at the cell membrane, or, equivalently, spatial fluctuations of IGF-
stimulating growth factors. We will exploit the linearity of our approx-
imation scenarios and compose an arbitrary initiator signal by means
of Fourier series.
Figure 3 depicts examples of the initial conditions IC1–IC4. In the following
sections, we will show the effect of the inhibitor I, for all the initial conditions
and scenarios. The absence of the inhibitor, will be represented by c3 = 0 in
Equation (7).
4. Scenario 1: High protein turnover or mild enzyme activation
4.1. Scenario definition and solution strategy
We now focus on a scenario where the auto–activation velocity is smaller
than the protein reproduction. Accordingly, the strength of auto–activation
k1 is assumed to be low (1a) in comparison to the turnover of both, the pro–
form P (1c) and the inhibitor I (1e), whose concentrations are considered to
remain constant and are denoted by c¯1 and c¯3, respectively.
Under these conditions, α in (7) becomes
α = k1c¯1 − k4c¯3 − k2. (8)
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We note that the solution to (6) has the form
c2(t, x) = exp (αt)u(t, x). (9)
Substituting it into (6), yields
∂
∂t
u(t, x) = d2∇2xu(t, x), (10)
which is the homogeneous heat equation with the initial condition u(0, x)
= g(x) in a infinite spatial domain. Using a Green function approach [28],
the solutions to the equation above are given by
u(t, x) =
∫ ∞
−∞
g(ξ)G(t, x, ξ)dξ, (11)
where G(t, x, ξ) is a Green function defined as
G(t, x, ξ) =
1
2
√
pidt
exp
(
−(x− ξ)
2
4dt
)
.
In the following, we will use Expression (11) to investigate the response of
the reaction network with different initial conditions.
4.2. IC1 - Spontaneous local activation
We assume a localised activation of Akt/mTOR at time point t = 0. The
initial condition g(x) is represented by
g(x) = δµ,
where δµ stands for a Dirac pulse in x = µ. Inserting g(x) into (11) leads to
u(t, x) =
1
2
√
pid2t
exp
(
−(x− µ)
2
4d2t
)
.
By substituting the expression above in (9), the profile of c2(t, x) is
c2(t, x) =
1
2
√
pid2t
exp
(
αt− (x− µ)
2
4d2t
)
. (12)
Let N (◦) be a Gaussian function defined as
N (x− µ, σ2) = 1√
2piσ2
exp
(
−(x− µ)
2
2σ2
)
. (13)
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with µ as maximum and σ as the standard deviation.
With this definition, we can express the spatio–temporal profile for c2(t, x)
in (12) as
c2(t, x) = exp(αt)N (x− µ, 2d2t). (14)
This expression is a Gaussian curve (Figure 4b upper and Figure 4c upper)
which is broadening linearly in time and whose amplitude is given by a time–
dependent exponential function. We will restrict α to be negative, non zero
values as otherwise the exponential term exp(αt) would grow without bound.
This would not only conflict with biological assumptions that proteins can-
not infinitely accumulate, but would also violate our assumptions that the
concentration of the activated form is low enough not to decrease the levels
of the pro–form of Akt/mTOR or the inhibitor. For the condition α < 0, the
maximum value for this Gaussian function is found at x = µ; i.e. at the lo-
cation where the spontaneous activation originally took place. We conclude
that a point–like activation of Akt/mTOR will remain localised, but will
broaden and decay over time. Figure 4 shows the comparison of the numer-
ical simulation of the model in (5) (Figure 4(a) upper) with the analytical
solution with and without inhibitor (Figure 4(b-c) upper, respectively). As
we can perceive, the effect of the inhibitor restrains the signals progression
in space. By comparison of panels Figure 4(a) upper and Figure 4(b) upper,
we note that the behaviour of the approximated Scenario 1, resembles that
of the numerical simulation.
4.3. IC2 - Receptor activation
We now study the effect of IFG-receptor activation, by representing ini-
tially active Akt/mTOR by a Gaussian distribution as an initial condition
(t = 0). By this, we assume that receptor activation at the cell membrane
extends over a finite spatial region at the cell surface. We define
g(x) = kN (x− µ, σ2),
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as initial signal with µ as location of maximum activation and σ as the
activation spread. Substitution of this initial condition into (11), leads to
u(t, x) =
k
2piσ
√
2d2t∫ ∞
−∞
k exp
(
−
[
σ2(x− ξ)2 + 2d2t(ξ − µ)2
4d2tσ2
])
dξ
u(t, x) =
k√
2pi(2d2t+ σ2)
exp
(
− (x− µ)
2
4d2t+ 2σ2
)
.
Substituting this last solution into (9), the spatio–temporal profile for c2(t, x)
gives
c2(t, x) =
k√
pi(4d2t+ 2σ2)
exp
(
αt− (x− µ)
2
4d2t+ 2σ2
)
c2(t, x) = k exp(αt)N (x− µ, 2d2t+ σ2). (15)
We note that Equations (10) and (11) translate an initial Gaussian function
into a Gaussian with a maxiumum at the same location (see Figure 4(b–
c) lower) whose amplitude is modulated by a time–dependent exponential
function. A numerical illustration of a typical solution of this scenario in the
presence or absence of an inhibitor is given in the lower panels of Figure 4,
where we also compare this approximative scenario to the exact solution of
the equation system (5) for a situation where enzyme activation is sufficiently
low and protein turnover sufficiently high.
Due to the linearity of (10), any composition of Gaussian functions as
initial condition, yields a composition of Gaussian functions. To show this,
consider the initial condition
g(x) =
N∑
i=1
kiN (x− µi, σ2i ).
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From (9) it follows that
u(t, x) =
∫ ∞
−∞
[
N∑
i=1
kiN (x− µi, σ2i )
]
G(x, ξ, t)dξ
=
N∑
i=1
[∫ ∞
−∞
kiN (x− µi, σ2i )G(x, ξ, t)dξ
]
u(t, x) =
N∑
i=1
kiN (x− µi, 2d2t+ σ2i ),
whence,
c2(t, x) = exp(αt)
N∑
i=1
kiN (x− µi, 2d2t+ σ2i ). (16)
As in the previous case, each Gaussian function will decay exponentially and
broaden linearly in time. We conclude that due to the linearity of scenarios 1,
receptor activations that happen at different spatial loci linearly superimpose.
This will allow us to study arbitray initial conditions (IC4).
4.4. IC3 - Localised depression of activation
We now study the situation where most of the cell surface is covered by
activated IGF receptors, while some regions either do not have any receptors,
these receptors are blocked or not accessible. For this, assume the initial
condition along x at t = 0 be represented by the function
g(x) = h(x)− h(x− τ) + h(x− (τ + γ)), (17)
where h(z) is the Heaviside step function, defined as
h(z) =
{
0 , z < 0
1 , z ≥ 0.
In (17), 0, τ and γ are the spatial locations where the function g(x) suddenly
changes its value. According to (9) and (11), the solution in this case is
u(t, x) =
1
2
[
erf
(
x
2
√
d2t
)
− erf
(
x− τ
2
√
d2t
)
+
+erf
(
x− (τ + γ)
2
√
d2t
)
+ 1
]
.
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Where
erf(z) =
2√
pi
∫ z
0
exp(−y2)dy,
and hence,
c2(t, x) =
1
2
exp(αt)
[
erf
(
x
2
√
d2t
)
− erf
(
x− τ
2
√
d2t
)
+
+erf
(
x− (τ + γ)
2
√
d2t
)
+ 1
]
. (18)
This solution shows that a discontinuous initial condition (see Figure 3(c))
will eventually ‘smoothen’ due to the diffusion effect, hence active signals re-
sulting from IGF activation will reach regions in the space in which originally
no activated enzyme was present. For high diffusion constant, the activated
enzyme may replete all the regions.
4.5. IC4 - Periodic initiator signal.
As demonstrated before, the linearity of (11) allows superimposition of
initiator signals. This enables us to study the most general case where IGF
receptor activation happens periodically over the entire cell surface. In order
to take into account any other 2pi–periodic initial condition, we consider we
have available the Fourier series of such a signal. Let this representation be
given by the infinite series
g(x) =
a0
2
+
∞∑
n=1
(an cos(nx) + bn sin(nx)) , (19)
where the coefficients an and bn are given by
a0 =
1
pi
∫ pi
−pi
g(ξ)dξ
an =
1
pi
∫ pi
−pi
g(ξ) cos(nξ)dξ
bn =
1
pi
∫ pi
−pi
g(ξ) sin(nξ)dξ.
Although this series requires the restriction to 2pi periodic signals, rescaling
of the space variable x allows to include any periodicity of the initial signal
g(x).
12
From (9) and (11) follows,
u(t, x) =
a0
2
+
∞∑
n=1
exp(−d2tn2) (an cos(nx) + bn sin(nx)) ,
which leads to
c2(t, x) =
a0
2
exp(αt) +
+
∞∑
n=1
exp((α− d2n2)t) (an cos(nx) + bn sin(nx)) . (20)
The solution to (11) driven by the initial condition in (19), preserves the
original infinite–series form. However, while the exponential damping factor
in (20) varies linearly in time, it dependes quadratically on the frequency
(n). Consequently, the system (6) acts as a low–pass filter.
4.6. Example for low–pass filtering
We now illustrate how the solution (11) establishes a low–pass filter, that
filters out spatial fluctuations in initial IGF receptor mediated signals. We
therefore consider the following initial signal as depicted in Figure 5(a)
g1(x) =
1
2
+ 0.3 sin (x) ,
which is an exemplification of (19) with the Fourier constant a0 = 1 and
b1 = 0.3, while other coefficients are zero. According to (20) the solution for
this particular initial condition is (Figure 5(d))
c2(t, x) =
1
2
exp(αt) + 0.3 exp((α− d2)t) sin(x).
Now, consider a different initiator signal composed as the sum of two sine
functions (Figure 5(b))
g2(x) =
1
2
+ 0.3 sin (x) + 0.05 sin (16x) .
with the Fourier coefficients for (19) being a0 = 1, b1 = 0.3, b16 = 0.05 and
the remaining coefficients being zero. This initiator signal yields the solution
c2(t, x) =
1
2
exp(αt) + 0.3 exp((α− d2)t) sin(x) +
+0.05 exp((α− 256d2)t) sin(16x).
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From this last equation we see that the term exp((α − 256d2)t) approaches
zero quickly. Therefore, high harmonics of the initiator signal are filtered
out as shown in Figure 5(e). As consequence both initiator signals g1(x) and
g2(x) will yield a similar spatiotemporal profile c2(t1, x) for a sufficient large
t1, regardless of their difference suggesting that reduced system (6) acts as
noise repressor.
4.7. Example for spatial fluctuations
Now, consider a ‘noisy’ Gaussian function as an initial condition, repre-
sented as
g2(x) = N (x− µ, σ2) + 0.005 sin (10x) .
This initial condition is depicted in Figure 5(c). Due to the linearity of the
heat equation, the solution (9) with the foregoing initial condition will be
the sum of two terms:
c2(t, x) = exp(αt)N (x−µ, 2d2t+σ2)+0.005 exp((α−100d2)t) sin(10x). (21)
Again, we note that the filtering effect of the heat equation will decrease
the spatial fluctuations, since the second element of the sum will decrease in
magnitude very quickly as time increases, as noted in the previous example.
The solution for t = tf = 0.15[s] is given in Figure 5(f).
4.8. Summary scenario 1
Table 1 summarises the closed–form expressions for the initial conditions
IC1–IC4. All solutions consist of a product of bounded function with an expo-
nential term. As the latter terms determines whether a solution is bounded
or not, their arguments must fulfill certain conditions given in Table 2 as
otherwise our assumptions of the invariance of [P ] and [I] are not anymore
fulfilled. Since the exponent α(t) must be negative, no ‘on steady state’ is
present. Likewise, as can be seen from the 1, no travelling wave exists (see
remarks regarding travelling waves in section 7.2. The absence of a stable
‘on state’ and, therefore, of travelling waves is explained by the fact that the
assumptions of this scenario (low auto–activation relative to a high protein
turnover) violate the assumption k2/k1 < k3b/k3f . This is consistent with the
situation in the space independent scenario, where no ‘on state’ is observed
when the auto–activation kinetic parameter was small compared to protein
protein production and degradation (1a).
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We conclude this section by noting that our analytical solutions allow
exact determination of those times and locations where a certain activation
threshold is exceeded (Appendix 7.3) and makes it possible to determine
those spatial regions of the muscle cell that may be affected by localised
receptor activation. This also allows to assess the effect of inhibitors of the
Akt/mTOR pathway such as PTEN that have been implicated in regulating
the threshold for Akt/mTOR signalling [11, 25].
5. Scenario 2: Highly regulated protein synthesis
5.1. Scenario definition and solution strategy
In the previous section we have harnessed the linearity of our approximate
equation (11) to study IGF receptor signal superposition and arbitrary IGF
activation signals. We now aim to provide a generalised scenario (denoted
here Scenario 2, yet this is actually a more general case) for that the assump-
tion of linearity remains valid so that the findings of the previous paragraph
can be translated into a more general framework. For this general scenario,
we assume that the spatial distribution of the pro–enzyme is isotropic and
its temporal profile is given a priori. This is equivalent to conditions where
protein levels are regulated by transcription/translation or by protein degra-
dation rather than by loss and gain through the protein signalling cascades.
Assuming a time–varying stimulus for c1 and a constant concentration
for c3, we obtain from (7)
α = α(t) = k1c1(t)− k4c¯3 − k2. (22)
Accordingly, (6) becomes
∂
∂t
c2 = d2∇2xc2 + α(t)c2. (23)
In order to write Equation (6) as a homogeneous heat equation we intro-
duce the auxiliary variable φ(t) that satisfies
φ˙(t) = α(t)φ(t), φ(0) = 1, φ(t) 6= 0 ∀ t ≥ 0, . (24)
This allows us to define the change of variables from c2(t, x) to u(t, x) as
c2(t, x) = φ(t)u(t, x), (25)
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which leads to the PDE
∂
∂t
{φ(t)u(t, x)} = d2∇2x {φ(t)u(t, x)}+
+α(t)φ(t)u(t, x)
∂
∂t
u(t, x) = d2∇2xu(t, x).
Expressions (25) and (24) imply that the initial conditions given to u(t, x),
are the same initial conditions as those given to c2(t, x). This can be seen as
follows
c2(0, x) = φ(0)u(0, x) = u(0, x). (26)
Consequently, by the transform (26) we have translated the dynamical
equation of Scenario 2 to a homogeneous heat equation equivalent to (11)
with the same boundary conditions as before. To obtain the respective solu-
tions, we only have to replace the exponential term in Table 1 by the auxiliary
variable φ(t). The respective solutions for the initial conditions IC1 – IC4
are given in Table 3. We note that, since the auxiliary function φ(t) is only
time dependent and since (26) is linear, the dynamical system in this scenario
acts also as a low-pass filter for spatial signal fluctuations. Typical auxiliary
functions φ(t) will be given in the next subsection.
5.2. Application to IGF activation during enzyme up and downregulation
Finally, we study activation profiles of active Akt/mTOR for situations
where levels of the inactive form are either monotonically up- or downreg-
ulated. This regulation is assumed to be caused by processes independent
from the auto–activation cascade. This assumption accounts for the presence
of intrinsic (non receptor mediated) stress that may enhance or block protein
production. As such, activation of the energy sensor AMPK that senses a
depletion of cellular ATP (and increase of AMP) has been shown to switch
off protein production [30]. Both, AMPK activation and IGF receptor stimu-
lation are simultaneously present during physical exercise and therefore may
act in a synergistic fashion. Moreover, cells may also up- or downregulate
their Akt/mTOR levels in response to pharmacophores [1].
To model up- and down regulation we set c1(t) to
c1(t) = k
−1
1
[
k2 + k4c¯3 − r + 2k
pi
arctan(st)
]
, (27)
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where we also assumed a constant inhibitor c¯3. Here, r is a term to adjust
the initial value of c1(t), s is the velocity for attaining a new steady state,
while k is the scaling factor that describes the amount of decrease (negative
k) or increase (positive k). From (22) we obtain,
α(t) = −r + 2k
pi
arctan(st), (28)
which allows us to obtain the auxiliary function φ(t) by using (24)
ln(φ(t)) =
∫
α(t)dt
ln(φ(t)) = −rt+ 2 k
spi
×
×
[
st arctan(st)− ln
(
(1 + (st)2)
1
2
)]
φ(t) =
(
1 + (st)2
)− k
spi exp (α(t)t) , φ(0) = 1. (29)
The temporal profile for c1(t) (see Figure 6a) as described in (27) together
with parameter variation of s and k allows us to study c2(t, x) in response
to IGF activation and in response to up- and down regulation of c1(t). We
consider the following situations:
1. Downregulation of the inactive pro-form: For modelling down-
regulation, k needs to be negative and |k| < [k2 + k4c¯3 − r], accord-
ing to (27) for maintaining positive c1(t). Note that c1(t) decreases
monotonously. As α(t) is negative, c2(t, x) decreases exponentially as
t increases, although this decrease is slightly attenuated by the first
factor. We note two phases of the exponential decay: i) for small t,
the arcus tangens can approximated by a linear function in t and the
second factor leads to an exponential decay quadratic in t. ii) For large
enough t, the arcus tangens is close to (pi/2) leading to an exponential
decay whose argument is linear in t. Figure 6c shows c2(t, x) when
a localised depression of activation (IC3) is considered, when c1(t) is
being downregulated, as in Figure 6a.
2. Upregulation of the inactive pro-form: Here k is positive and c1(t)
increases to a maximum value. Moreover, α(t) < 0 needs to be negative
as otherwise c2(t, x) grows without bound. Therefore, protein levels of
c1(t) in (27) must be less than (k2 + k4c¯3) /k1 suggesting that not all
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protein productions are biologically possible. Under these conditions,
the exponential decay of c2(t, x) remains dominant. Figure 6b shows
c2(t, x) under IC3 and c1(t) upregulation.
3. Reduction to scenario 1: If k is set to zero, α(t) and c1 are con-
stant. With negative α(t) = −r, the auxiliary function φ(t) turns into
a linearly decaying exponential function and the solution of Scenario 1
are obtained (see Table 1).
Anew, in all above situations, the active Akt/mTOR form c2(t) decreases
with time and, according to Table 1, no travelling waves exist. In conclusion,
in Scenario 2 we assumed spatially invariant, but temporarily variant protein
profiles of the pro–form that are imposed by other processes than receptor
activation, such as energy stress. We found that assuming such profiles did
not change the fact that spatial fluctuations in IGF receptor activation are
filtered out, resulting in a more homogeneous Akt/mTOR activation.
6. Summary and Discussion
In this study, we provided an analytical approach to investigate signal
transduction in time and space in large, but thin cells mediated by a simple
auto–activation loop and a receptor stimulus. By applying our approach
to growth (changes in diameter) in skeletal muscle cells, we have gained
insights into the question under what circumstances a stable activation of
AKT/mTOR can be achieved and how spatial anisotropies may be translated
into a homogeneous response along the entire cell. We first focussed on
time dependent, but spatially invariant signal propagation and determined
conditions for a stable AKT/mTOR activation. These conditions required
the strength of auto-feedback to be high compared to protein turnover.
We investigated spatiotemporal signal propagation assuming four differ-
ent initiator signals that describe IGF receptor activation. To solve them
analytically, we have developed biologically justified scenarios. We first con-
sidered a scenario where protein turnover was faster compared to enzyme
auto–activation. The distribution of the active enzyme was found to broaden
in space (yet staying localised) and its magnitude was decaying exponentially
over time. Unlike in a general scenario, where a stable ‘on state’ and travel-
ling waves may exist, no such state and no travelling waves were found under
our scenario assumptions. Our results therefore suggest that high protein
turnover may ‘wash out’ the active pro–form, keeping it locally confined to
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the place where they originated from (e.g. IGF receptor). Indeed, there are
evidences in literature where enzymes that lead to a more severe response
such as cell–cycle arrest or cell death when they act over the entire cell, have
a distinctive, physiological role when they are spatially and temporally lo-
calised [36]. As an example, proteases that mediate cell death in other large
cells such as nerve cells are essential for the physiological process of long–
term potentiation when their activity remains localised at the nerve cells’
synapses [20].
Changes in protein turnover may therefore mediate between a localised
physiological and a global detrimental role of the same enzyme.
In scenario 2, we assumed to know the amount of pro–enzyme that is
available at a given time. This is equivalent to study signal progression
under variation of protein production. Such variations may arise from phys-
iological or pharmacologic inhibition of protein production or, in contrast,
from elevation of protein production induced by trophic factor stimulation
or pharmacologic treatments [4, 8, 13, 27]. Also under these assumptions, no
stable ‘on state’ and no travelling waves were identified.
For both approximation scenarios, the dynamics of the active form was
governed by a homogeneous heat equation and therefore by a linear PDE.
Thus, studying these scenarios analytically, we were able to superimpose so-
lutions and represent a general receptor activation by Fourier series. While
the exponent responsible for damping the Gaussian pulses was found to be
linear in time, it was a quadratic function of the frequency of the harmonics
that compose the original signal. As consequence, the contribution of har-
monics with higher frequencies approach zero faster. By this, auto–activation
together with diffusion can act as low–pass filters. This filter can translate
spatial fluctuations arising from spatial heterogeneity in IGF activation into
a more uniform distribution of enzyme activation.
In conclusion, our study highlights the importance of studying spatiotem-
poral signal transduction in large cells by rigorous mathematical methods
and helped to elucidate how receptor mediated signals can propagate or can
get attenuated, and how spatial fluctuations of receptor activation can be
filtered. While our study was motivated by mTOR/AKT kinase signalling
networks, the results can be applied to a variety of cases such as MAPK sig-
nalling during cell proliferation [32], protease cascades during cell death [16],
and the establishment of cell polarity by morphogens during development [5]
in any large cell or cell compartment.
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7. Appendix
7.1. Autoactivation of Akt
In this section, we show how the mTOR/Akt interaction leads to an Akt
autoactivation, when the mTOR levels can be considered constant. This can
happen i) under the presence of a big pool of mTOR in comparison to the
Akt pool, or ii) the mTOR concentration is kept constant due to high a
turnover rate.
In order to reduce the pathway, we will consider that the extracellular
stimulus of insulin is translated via the IGF receptor into an initial condition
of phosphorilised Akt (Akta). The inactive version of Akt (Akt) can also
be activated by its interaction with mTOR. Here mTOR represents the
mTOR complex under physiological conditions, which we assume to keep a
constant concentration due to high turnover rates, or due to the abundance
of mTOR so the Akt/mTOR interaction does not deplete the mTOR pool,
significantly. Also, Akta is further deactivated and degraded. Moreover, we
will include the effect of an inhibitor of Akta, which will be denoted by I.
Finally, both Akt and I will be endowed with a synthesis and degradation.
These interactions and effects are summarised by the forthcoming reactions:
Akta
k˜0−→ mTOR + Akta (30a)
Akt+mTOR
k˜1−→ Akta +mTOR (30b)
Akta
k2−→ 0 (30c)
Akt
k3f−−⇀↽−
k3b
0 (30d)
Akta + I
k4−→ 0 (30e)
I
k5f−−⇀↽−
k5b
0 (30f)
Writing one after another the reactions (30a) and (30b), we have
Akt+ Akta
k˜0−→ mTOR + Akta + Akt k˜1−→ 2Akta +mTOR. (31)
Note that we have added Akt as a product and a reactant to the first reaction
without assuming it to have an impact on the reaction rate k0. This was done
20
to include Akt as a reactant for the second reaction in (31). Now, if k˜0 >> k˜1,
we can reduce the reaction (31) to
mTOR + Akta + Akt
k˜1−→ 2Akta +mTOR (32)
or more compactly, as
Akt+ Akta
mTOR×k˜1−−−−−−→ 2Akta (33)
By choosing P = Akt, A = Akta, and k1 = mTOR × k˜1; we can express
the network in (30) as
P + A
k1−→ 2A
A
k2−→ 0
P
k3f−−⇀↽−
k3b
0
A+ I
k4−→ 0
I
k5f−−⇀↽−
k5b
0.
Note that this is the same reaction network as presented in (1).
7.2. Travelling waves
Travelling waves are fronts of active enzymes that propagate along space
and time with a constant shape. Although their presence can be easily shown
numerically, analytical proofs of their existence remain cumbersome. We
here refer to an existence proof that applies to a restricted scenario. In this
scenario, we only consider the auto–activation reaction (1a) and assume at
the same time that the sum of concentrations of the active and the inactive
form remains conserved, Z = P +A = const. This assumes that production
of the inactive form, generation of the active form by auto–activation and
degradation of the active form are well balanced. We note that, in contrast
to our scenarios in the main text, this assumption does not require protein
production to be fast or auto–activation to be slow. The dynamic equation
for the concentration of the active enzyme [A] takes the form
∂
∂t
[A] = d2∇2x[A] + k1[A]([Z]− [A]). (34)
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Assuming proper scaling units, we consider the concentration of the total
protein to be normalised, [Z] = 1. Equation (34) is then known as the
Fisher–Kolmorov equation, which was first proposed by Fisher [10] and later
studied by Kolmogorov [19]. Conditions for the existence of travelling waves
were derived in [10] and reviewed in [24], Chap. 13, where we refer the reader
for details. These conditions indicate that wave speed should be greater
than 2(k1D)1/2 in order to obtain a phase portrait with a heterocyclic curve
connecting the saddle point with the stable node in the equivalent set of ODE
derived from the PDE. Under these circumstances, the solution of the PDE
system will evolve to a travelling wavefront whenever the initial conditions
are a step function for receptor activation, i.e.
[A](x, 0) =
{
1 if x ≤ x1
0 if x ≥ x2.
with x1 < x2 and x1 < x < x2.
We finally remark that taking into account arbitrary protein production
and degradation as in the full dynamic system (1) requires an analysis that
accounts for variations of Z over time.
7.3. Investigating thresholds from analytical solutions
In this section, we discuss how the availability of analytical solution can
help to determine those spatial regions of a muscle cell where the Akt/mTOR
activation exceeds a certain threshold. Indeed, Akt and mTOR have been
shown to exert their role as a growth signal only when certain thresholds are
reached. The Akt/mTOR antagonist PTEN has been shown to regulate these
thresholds [11, 25]. We will further motivate how threshold determination
from analytical solutions may aide in determining the applicability of mass
action kinetics in our scenario. We will focus here on the closed formulas for
the active form c2(t, x) that were obtained in the receptor activation scenario
IC2 (15) in Section 4. Assumings a threshold (c˜2) for c2, we obtain
c˜2 ≤ k√
pi(4d2t+ 2σ2)
exp
(
αt− (x− µ)
2
4d2t+ 2σ2
)
.
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From above equation, we can obtain the area around the original centre of
activation µ where the threshold is exceeded at a certain time t
|x− µ| ≤
√
(4d2t+ 2σ2)
[
αt− 1
2
ln (k−2c˜22pi(4d2t+ 2σ2))
]
.
(35)
We recall that the dynamical system (1) was modelled by mass–action kinet-
ics. Consequently, Equation (35) may serve to evaluate whether or not the
conditions of mass action kinetics (sufficiently high values of c1 and c2) are
fulfilled and whether or not c2 is reliable in this area. Otherwise stochastic
effects have to be taken into account. We further note that valid thresh-
olds c¯2 require the argument of the square root to be positive and there-
fore Equation (35) allows to validate whether a threshold is reached or not.
Comparing spatial patterns of exceeded thresholds (35) to experiments that
measure the result of mTOR/AKT activation (such as spatial regions of mus-
cle growth), may therefore give insights into the quantitative kinetics (k, d2)
of Akt/mTOR activation and into the kinetics of Akt/mTOR inhibition by
PTEN. Finally, we remark that the diffusion constant has a direct relation-
ship to the size of the area exceeding the threshold, whereas the inhibitor
tends to confine the signal to its original location. An example of threshold
determination over space is given in Figure 7.
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Table 1: Spatio–temporal evolution for the mild enzyme activation scenario (Scenario 1)
under different initial conditions
Initial Condition Spatio–temporal behaviour (c2(t, x))
Point–like activation exp(αt)N (x− µ, 2d2t)
Receptor activation exp(αt)
∑N
i=1 kiN (x− µi, 2d2t+ σ2i )
1
2
exp(αt)
[
erf
(
x
2
√
d2t
)
− erf
(
x−τ
2
√
d2t
)
+
Localised depression of activation erf
(
x−(τ+γ)
2
√
d2t
)
+ 1
]
a0
2
exp(αt) +
∑∞
n=0 exp((α− d2n2)t)×
Arbitrary periodic signal (an cos(nx) + bn sin(nx))
Table 2: Conditions for the stability of the solutions to Equation (6) for Scenario 1 and
different initial conditions
Initial Condition Stability condition
Point–like activation c¯1 <
k2+k4c¯3
k1
+ x
2
4k1d2t2
Receptor activation c¯1 <
k2+k4c¯3
k1
+ x
2
k1(4d2t+2σ2)t
Localised depression of activation c¯1 <
k2+k4c¯3
k1
Arbitrary periodic signal c¯1 <
k2+k4c¯3
k1
Table 3: Spatio–temporal evolution for the stress–induced enzyme activation scenario
(Scenario 2) under different initial conditions. Where α(t) and φ(t) are defined in (28)
and (29), respectively.
Initial Condition Spatio–temporal behaviour (c2(t, x))
Point–like activation φ(t)N (x− µ, 2d2t)
Receptor activation φ(t)
∑N
i=1 kiN (x− µi, 2d2t+ σ2i )
1
2
φ(t)
[
erf
(
x
2
√
d2t
)
− erf
(
x−τ
2
√
d2t
)
+
Localised depression of activation erf
(
x−(τ+γ)
2
√
d2t
)
+ 1
]
a0
2
φ(t) +
∑∞
n=0 φ(t) exp(−d2n2t)×
Arbitrary periodic signal (an cos(nx) + bn sin(nx))
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AKT/mTOR
P: Inactive pool of 
A: Active pool of 
     Akt and mTOR.
      Akt and mTOR.
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L
Figure 1: AKT/mTOR pathway activation by IGF stimulation. The panel (a) shows a
spatially extended cell (L >> d), with IGF receptors (IGF-R) that are activated by binding
of IGF ligands (IGF-L). Upon binding, the active signal that originates at the receptor
propagates through the cell. The diameter d of the cell is neglected. The behaviour of
the active signal at each spatial location is analysed in the main text. Panel (b) details
how the receptors activation results in PI3 kinase activation and a subsequent positive
feedback loop of Akt and mTOR. Moreover, the effect of an inhibitor I of such a pathway
is considered. Panel (c) illustrates the abstraction of Akt and mTOR into one simple node
which auto–activates itself as considered in this study. This auto–feedback is assumed to
convert inactive versions of Akt/mTOR (P ) to their respective active forms (A).
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Figure 2: Trajectories and phase portrait due to two different initial conditions for the
system in (3). Panel (a) shows the fixed point loci of the active enzyme A concentration
(c¯2) due to variation on the feedback strength (k1). In turn, Panel (b) and (c) depict c1(t)
and c2(t), respectively. Finally, d) shows a phase portrait where we plot the active form
c2(t) vs the inactive form c1(t). The dot (square) represents (un–)stable steady state and
the circles, the initial conditions for each orbit. We see that all the orbits converge to
the stable fixed point, except for those whose c2(0, x) coordinate is zero. This indicates
that unstable steady state is a saddle point; in turn, the stable steady state is a focus.
Parameters {k1, k2, k3f , k3b} = {0.055, 0.2, 0.01, 0.05}[(µMs)−1].
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Figure 3: Illustration of typical initial conditions IC1–IC4 as described in Section 4: (a)
Dirac delta pulse in the origin, (b) Gaussian curve, (c) a composition of steps, (d) a typical
periodic signal.
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Figure 4: Numerical solution of the exact solution for c2(t, x) in Eq. (5) (panels (a)) and
the approximated Scenario 1 (Eq. (6)) with and without inhibitor (panels (b) and (c),
respectively). The upper panels, show the spatiotemporal profile for c2(t, x) with a the
point like activation as initial condition (IC1). In turn, the lower panels, shows c2(t, x) for
a receptor activation (IC2). The presence (absence) of the inhibitor in the columns (b)
and (c), is represented by c¯3 = 0 (10)[µM ]. In conclusion, the similarity of results in col-
umn (a) and (b) illustrate Scenario 1 as a valid approximation when protein turnover
is high compared to strength of auto–activation. Parameters {k1, k2, k3f , k3b, k4} =
{k2/5, 0.2, 0.01, 0.05}[(µMs)−1], kin = 0.5, d2 = 24[µm2/s], σ = 1.7.
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Figure 5: Initial conditions and the solution of Scenario 1 (Eq. (6)), under such initial
conditions. The panel (a) depicts a sinusoidal signal of a single frequency; in turn, panel
(b) shows a sum of low and high frequency sine functions; finally, panel (c) shows a ‘noisy’
Gaussian function with µ = 0 and σ2 = 1.7. The panels (d–f) depict the solution to (6) at
t = tf = 0.15[s] for the initial conditions (a–c), respectively. We note that in the case of
noisy signals, the effect of the noise vanishes, as the time proceeds. Parameters: α = −1.
Kinetic and diffusion parameters are as in Figure 4.
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Figure 6: Solution of Scenario 2 (Eq. (6)) under the initial condition IC3 (localised
depression of activation). a) Represents up- and downregulation (dashed and dotted line,
respectively) of c1(t) according to cases 1 and 2 in Section 5.2 and given by (27). The panels
(b) and (c) show c2(t, x) when c1(t) is being upregulated and downregulated, respectively,
as shown in panel (a). Furthermore, the upper and lower panels of (b) and (c) present
c2(t, x) with and without inhibitor. We note that the effect of the upregualtion of c1(t)
is a more steady signal progression. Parameters τ = 5, and γ = 15, s = 1. Upregulation:
{r, k} = {0.1, 0.1}. Downregulation: {r, k} = {0.1,−0.1}. The rest of the parameters are
as in Figure 4.
34
−10 −5 0 5 10
0.05
0.1
0.15
0.2
0.25
c 2
(x)
 [µ
 
M
]
a)No Inhibitor, low diffusion
 
 
c2(0,x)
c2(t1,x)
−10 −5 0 5 10
0.05
0.1
0.15
0.2
0.25
b)No Inhibitor, high diffusion
 
 
c2(0,x)
c2(t1,x)
−10 −5 0 5 10
0.05
0.1
0.15
0.2
0.25
c 2
(x)
 [µ
 
M
]
Spatial dimension
x [µ m]
c)Inhibitor, low diffusion
 
 
c2(0,x)
c2(t2,x)
−10 −5 0 5 10
0.05
0.1
0.15
0.2
0.25
Spatial dimension
x [µ m]
d)Inhibitor, high diffusion
 
 
c2(0,x)
c2(t2,x)
Figure 7: Example of detecting spatial regions in which a concentration threshold (hori-
zontal dotted line) is exceeded. For Scenario 1, we consider a Gaussian initial condition
(depicted in a dotted line) with µ = 0 and σ2 = 1.7. The panel a) shows the behaviour
of the active form c2(t1, x) in the absence of inhibitor and with low diffusivity (dl); in
turn, b) depicts c2(t1, x) without inhibitor, but with a higher diffusion constant (dh).
Accordingly, c) and d) represent c2(t2, x) in the presence of inhibitor with low and high
diffusion constants, respectively. The times t1 and t2, have been chosen close to the
time in which the maximal signal propagation is observed. As we can see, an increase
in the diffusion constant or the presence of an inhibitor lead to a decrease in the sig-
nals spatial spread. All the curves have been obtained from the formulas in Table 1.
Parameters: {k1, k2, k4} = {0.04, 0.2, 8.3}[(µMmin)−1]; {dl, dh} = {30, 300}[µm2/min];
{σ2, µ} = {2, 0}; {c¯1, c¯3} = {5, 10}[µM ]; {t1, t2} = {0.0357, 0.0035}[min].
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